Hexo | |||||
NEWS | |||||
The 3 Most Important Numbers in HEXO's Horrible Q2 Results HEXO (NYSE:HEXO) announced its fiscal 2020 second-quarter results before the market opened on Monday. And those results weren't what investors ...
| |||||
Hexo Analysts Project Continued Underperformance After Q2 Report The most important factors in Hexo's second-quarter report were: no improvement in cash burn, lower gross profit per gram and worsening operating ...
| |||||
Hexo's Need for Cash Raises Concern; Analyst Says 'Sell' HEXO admitted that in order to fund operations in the current fiscal year it will need to raise additional capital. A difficult task in such times. Bennett ...
| |||||
Why Did Shares of HEXO Plunge 28% Yesterday? (HEXO) reported second-quarter fiscal 2020 financial results before the market opened. Despite its tremendous rally last week, the stock plummeted 28 ...
| |||||
Edited Transcript of HEXO.TO earnings conference call or presentation 30-Mar-20 12:30pm GMT Good morning, and welcome to HEXO Corp.'s Second Quarter Fiscal 2020 Earnings call. (Operator Instructions) Please note that this call is being ...
| |||||
HEXO is facing a storm of negativity, AltaCorp says Shares of HEXO were up sharply on Tuesday after the company released its second quarter fiscal 2020 results, featuring total revenue of $17.0 million ...
| |||||
HEXO falls 27% on dismal fourth-quarter results, cannabis stocks tumble As such, the two companies that reported their quarterly results today, HEXO (NYSE:HEXO) and Cronos Group (NASDAQ:CRON), were met with ...
| |||||
Large Impairment Charges Send HEXO Stock Plummeting 28% In One Day Just last week, HEXO was one of several pot stocks that rode a sector-wide rally which followed the general stock market upswing in the wake of the ...
| |||||
Analysts Offer Insights on Healthcare Companies: HEXO (HEXO) and Knight Therapeutics ... HEXO has an analyst consensus of Moderate Sell, with a price target consensus of $1.19, which is a 28.0% upside from current levels. In a report issued ...
| |||||
Current Technicals:: HEXO Corp., (NYSE: HEXO) HEXO Corp., belongs to Healthcare sector and Drugs – Generic industry. The company's Market capitalization is $224.45M with the total Outstanding ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar